Hepatitis B virus induces sorafenib resistance in liver cancer via upregulation of cIAP2 expression
Abstract Background HBV promotes cell survival by upregulating the expression of the cellular inhibitor of apoptosis protein 2 (cIAP2), however whether it is involved in HBV-induced sorafenib resistance in liver cancer remains unclear. Methods cIAP2 overexpression and knockdown was adopted to assess...
Gardado en:
| Principais autores: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2021-03-01
|
| Series: | Infectious Agents and Cancer |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s13027-021-00359-2 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|